Paper75485
Non-appearance of injected fibroblast interferon in circulation.
Edy VG and 2 others. Lancet, 1978. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Non-appearance of injected fibroblast interferon in circulation. Papers, record 75485. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75485
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferons | Major topic |
| Embryo, Mammalian | |
| Female | |
| Fibroblasts | |
| Humans | |
| Injections, Intramuscular | |
| Leukocytes | |
| Pregnancy |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,654,159 | Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/8654159 | PubMed |
| 7,354,125 | Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits. | J Clin Microbiol | 1980 | https://conductscience.org/library/papers/7354125 | PubMed |
| 6,400,034 | The clinical application of fibroblast interferon--an overview. | Med Oncol Tumor Pharmacother | 1984 | https://conductscience.org/library/papers/6400034 | PubMed |
| 6,177,461 | Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release. | Clin Exp Immunol | 1982 | https://conductscience.org/library/papers/6177461 | PubMed |
| 6,166,278 | Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice. | Arch Virol | 1981 | https://conductscience.org/library/papers/6166278 | PubMed |
| 6,165,341 | Differences between human alpha (leukocyte) and beta (fibroblast) interferons. | Arch Virol | 1981 | https://conductscience.org/library/papers/6165341 | PubMed |
| 6,163,417 | Interferon therapy: pharmacokinetic and pharmacological aspects. | Arch Virol | 1981 | https://conductscience.org/library/papers/6163417 | PubMed |
| 6,160,588 | Spontaneous production of human interferon. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6160588 | PubMed |
| 3,897,068 | Attempted treatment of fulminant viral hepatitis with human fibroblast interferon. | Infection | 1985 | https://conductscience.org/library/papers/3897068 | PubMed |
| 3,308,943 | Assessment of the antigenic response in humans to a recombinant mutant interferon beta. | J Clin Immunol | 1987 | https://conductscience.org/library/papers/3308943 | PubMed |
| 2,443,533 | Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/2443533 | PubMed |
| 475,375 | Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/475375 | PubMed |
| 92,398 | Antiviral agents: action and clinical use. | Drugs | 1979 | https://conductscience.org/library/papers/92398 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/75485
GET https://conductscience.org/api/papers/v1/75485/authors